Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #18,251 to #18,300.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Angular resolution (1 revision)
  2. Anidulafungin warnings and precautions (1 revision)
  3. Aniline (1 revision)
  4. Aniline Blue WS (1 revision)
  5. Anilinium chloride (1 revision)
  6. Animal fat (1 revision)
  7. Animal geographies (1 revision)
  8. Animal heme-dependent peroxidases (1 revision)
  9. Animal locomotion (1 revision)
  10. Animal morphology (1 revision)
  11. Animal physiology (1 revision)
  12. Animal testing (1 revision)
  13. Animal testing on frogs (1 revision)
  14. Animal testing on invertebrates (1 revision)
  15. Animal testing on rodents (1 revision)
  16. Animals in space (1 revision)
  17. Aniracetam (1 revision)
  18. Aniseikonia (1 revision)
  19. Anisindione (patient information) (1 revision)
  20. Anisocoria (1 revision)
  21. Anisodus (1 revision)
  22. Ankle (1 revision)
  23. Ankle jerk reflex (1 revision)
  24. Ankylosing spondylitis case study one (1 revision)
  25. Ankylosing spondylitis cost-effectiveness of therapy (1 revision)
  26. Ankylosing spondylitis electrocardiogram (1 revision)
  27. Ankylosing spondylitis future or investigational therapies (1 revision)
  28. Ankylosis (1 revision)
  29. Ankyrin repeat (1 revision)
  30. Ankyrin repeat domain 22 (1 revision)
  31. Ankyrin repeat domain 33 (1 revision)
  32. Ankyrins (1 revision)
  33. Anna Balazs (1 revision)
  34. Anna Freud (1 revision)
  35. Annals of Emergency Medicine (1 revision)
  36. Annals of Internal Medicine (1 revision)
  37. Annelid (1 revision)
  38. Annexin A11 (1 revision)
  39. Annexin A13 (1 revision)
  40. Annexin A2 (1 revision)
  41. Annexin A4 (1 revision)
  42. Annexin A6 (1 revision)
  43. Annexin A9 (1 revision)
  44. Annihilation (1 revision)
  45. Annual ryegrass toxicity (1 revision)
  46. Annular pancreas MRI (1 revision)
  47. Annular pancreas case study one (1 revision)
  48. Annular pancreas cost-effectiveness of therapy (1 revision)
  49. Annular pancreas epidemiology and demographics (1 revision)
  50. Annular pancreas future or investigational therapies (1 revision)

View ( | ) (20 | 50 | 100 | 250 | 500)